NXTS Latest Press Releases

-- November 5, 2026 --

Nexentis Announces Reverse Stock Split Globe Newswire 9:00 AM

-- October 29, 2026 --

Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz Globe Newswire 7:22 AM

-- October 26, 2026 --

Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage Globe Newswire 8:16 AM

-- October 12, 2026 --

Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis Globe Newswire 8:07 AM

-- October 7, 2026 --

Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud Globe Newswire 7:32 AM

-- September 24, 2026 --

Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board Globe Newswire 7:50 AM

-- September 23, 2026 --

Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery Globe Newswire 7:07 AM

-- July 28, 2026 --

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign Globe Newswire 8:06 AM

-- July 7, 2026 --

Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative Globe Newswire 8:25 AM

-- June 29, 2026 --

Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation - Significant Premium to Initial Investment Globe Newswire 8:20 AM

-- June 22, 2026 --

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery Globe Newswire 8:22 AM

-- June 17, 2026 --

Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases Globe Newswire 7:32 AM

Market Data Delayed 15 Minutes